CY1752A - 8a-Acylaminoergoline its preparation and pharmaceutical compositions containing it - Google Patents

8a-Acylaminoergoline its preparation and pharmaceutical compositions containing it

Info

Publication number
CY1752A
CY1752A CY175294A CY175294A CY1752A CY 1752 A CY1752 A CY 1752A CY 175294 A CY175294 A CY 175294A CY 175294 A CY175294 A CY 175294A CY 1752 A CY1752 A CY 1752A
Authority
CY
Cyprus
Prior art keywords
acylaminoergoline
preparation
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
CY175294A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1752A publication Critical patent/CY1752A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
CY175294A 1987-06-23 1994-06-03 8a-Acylaminoergoline its preparation and pharmaceutical compositions containing it CY1752A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3720656 1987-06-23

Publications (1)

Publication Number Publication Date
CY1752A true CY1752A (en) 1994-06-03

Family

ID=6330087

Family Applications (1)

Application Number Title Priority Date Filing Date
CY175294A CY1752A (en) 1987-06-23 1994-06-03 8a-Acylaminoergoline its preparation and pharmaceutical compositions containing it

Country Status (28)

Country Link
US (1) US5075318A (xx)
JP (1) JPH0670052B2 (xx)
KR (1) KR970001527B1 (xx)
AT (1) AT395242B (xx)
AU (1) AU615657B2 (xx)
BE (1) BE1004034A3 (xx)
CA (1) CA1302404C (xx)
CH (1) CH674646A5 (xx)
CY (1) CY1752A (xx)
DK (1) DK169335B1 (xx)
ES (1) ES2010282A6 (xx)
FI (1) FI88302C (xx)
FR (1) FR2617166B1 (xx)
GB (1) GB2206115B (xx)
GR (1) GR1002318B (xx)
HK (1) HK2794A (xx)
HU (2) HU203097B (xx)
IE (1) IE60550B1 (xx)
IL (1) IL86820A (xx)
IT (1) IT1219652B (xx)
LU (1) LU87251A1 (xx)
MY (1) MY103584A (xx)
NL (1) NL8801597A (xx)
NZ (1) NZ225112A (xx)
PH (1) PH24690A (xx)
PT (1) PT87781B (xx)
SE (1) SE467925B (xx)
ZA (1) ZA884505B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
JP3630888B2 (ja) * 1996-10-31 2005-03-23 株式会社ニデック レンズ搬送装置と眼鏡レンズを搬送するための眼鏡レンズ用固定カップ及びレンズ搬送方法
BRPI0920246A2 (pt) 2008-10-17 2017-06-27 Winconsin Alumni Res Foundation método de preparação de alfa-beta peptídios biologicamente ativos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
NL8503426A (nl) * 1984-12-24 1986-07-16 Sandoz Ag 8alfa-acylamino-ergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.

Also Published As

Publication number Publication date
IE881867L (en) 1988-12-23
FR2617166A1 (fr) 1988-12-30
HK2794A (en) 1994-01-21
AU1819488A (en) 1989-01-05
MY103584A (en) 1993-08-28
HU211651A9 (en) 1995-12-28
GR1002318B (el) 1996-05-13
FR2617166B1 (fr) 1992-07-17
GB2206115B (en) 1991-04-03
DK169335B1 (da) 1994-10-10
CA1302404C (en) 1992-06-02
SE467925B (sv) 1992-10-05
KR890000479A (ko) 1989-03-14
JPS6422876A (en) 1989-01-25
JPH0670052B2 (ja) 1994-09-07
IE60550B1 (en) 1994-07-27
AU615657B2 (en) 1991-10-10
PH24690A (en) 1990-09-07
NZ225112A (en) 1991-03-26
AT395242B (de) 1992-10-27
IL86820A0 (en) 1988-11-30
IT8848097A0 (it) 1988-06-17
FI88302B (fi) 1993-01-15
ATA161788A (de) 1992-03-15
BE1004034A3 (fr) 1992-09-15
SE8802323D0 (sv) 1988-06-21
ZA884505B (en) 1990-02-28
NL8801597A (nl) 1989-01-16
HU203097B (en) 1991-05-28
US5075318A (en) 1991-12-24
GR880100401A (el) 1989-03-08
PT87781A (pt) 1989-05-31
HUT50174A (en) 1989-12-28
ES2010282A6 (es) 1989-11-01
FI883008A0 (fi) 1988-06-22
GB2206115A (en) 1988-12-29
IT1219652B (it) 1990-05-24
FI883008A (fi) 1988-12-24
FI88302C (fi) 1993-04-26
LU87251A1 (fr) 1989-03-08
IL86820A (en) 1991-07-18
SE8802323L (sv) 1988-12-24
KR970001527B1 (ko) 1997-02-11
CH674646A5 (xx) 1990-06-29
GB8814615D0 (en) 1988-07-27
PT87781B (pt) 1992-10-30
DK340188D0 (da) 1988-06-21
DK340188A (da) 1988-12-24

Similar Documents

Publication Publication Date Title
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
IL95351A0 (en) 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
NZ220345A (en) Imidazoquinolinylether derivatives and pharmaceutical compositions containing them
IL88156A (en) Azacyclic compounds their preparation and pharmaceutical compositions containing them
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
GR871659B (en) Substituted a-aminoacids their preparation and pharmaceutical compositions containing them
IL85896A0 (en) Substituted di-tert.-butylphenols and pharmaceutical compositions containing them
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
IL86086A0 (en) Bifunctional proteins and pharmaceutical compositions containing them
IL88433A0 (en) Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
IL87644A0 (en) Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them
IL82205A0 (en) Substituted alkanesulfonamidophenyl derivatives and pharmaceutical compositions containing them
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
CY1739A (en) Piperazinecarboxylic acid its preparation and pharmaceutical compositions containing it
IL89155A0 (en) Ouabain-like compounds and pharmaceutical compositions containing them
IL86926A0 (en) 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them
NZ219748A (en) Indenopyrimidines and pharmaceutical compositions
IL92650A0 (en) Polyhydroxybenzyloxypropanolamides and pharmaceutical compositions containing them
CY1752A (en) 8a-Acylaminoergoline its preparation and pharmaceutical compositions containing it
IL85824A (en) Pyrrolealdehydes,their preparation and pharmaceutical compositions containing them
IL78707A (en) Rioprostil-polyvinyl-pyrrolidone complex and pharmaceutical compositions containing it
IL85524A0 (en) Heterocyclyl-2-propyn-1-amines and pharmaceutical compositions containing same